Redeye updates its estimates following Sozap’s Q3 report. The Q3 figures came in somewhat softer in terms of sales, while profitability was slightly better than expected due to lower opex. We expect an uptick in sales in the coming quarter due to the launch of Questopia.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases